The ∼ 150 kDa single-chain neurotoxin produced by Clostridium butyricum, reported to be similar to C. botulinum neurotoxin serotype E ( Giménez and Sugiyama, Infect. Immun. 54, 926–929, 1988), was probed with trypsin and endoproteinase Lys-C. The two proteases cleaved the butyricum neurotoxin between residues Arg 421-Lys 422 and Lys 418-Gly 419, respectively. Cleavage at this region, highly susceptible to proteolysis, generated ∼ 50 kDa light and ∼ 100 kDa heavy chains, whose identities were established by amino acid sequence determination. In the ∼ 150 kDa dichain neurotoxin these two chains remained linked by an interchain disulfide bond. The endoproteinase Lys-C also cleaved the heavy chain between residues Lys 594-Ile 595, yielding a ∼ 73 kDa fragment. A total of 77 amino acid residues was identified by Edman degradation of the major fragments generated by proteolysis. By analogy with other botulinum neurotoxin serotypes, the light chain contains the intracellular inhibitory domain and the heavy chain the receptor-binding and channel-forming domains. Butyricum neurotoxin, whether in single-chain or dichain form, inhibited ∼ 70% of the Ca 2+ stimulated [ 3H]norepinephrine release from permeabilized PC12 cells. Reduction with 5 mM dithiothreitol enhanced the intracellular inhibitory activity of dichain neurotoxin about 30-fold and increased the extent of inhibition to about 80%, while the activity of single-chain neurotoxin was slightly affected. Increase in the intracellular inhibitory activity of butyricum neurotoxin following mild treatment with trypsin (i.e. conversion of the single-chain protein to the dichain form) was virtually complete within 6 min.